Placental tissue grafts and improved methods of preparing and using the same
US-2016030633-A1 · Feb 4, 2016 · US
US10105398B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10105398-B2 |
| Application number | US-201414286623-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 23, 2014 |
| Priority date | Feb 14, 2011 |
| Publication date | Oct 23, 2018 |
| Grant date | Oct 23, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein are compositions composed of micronized placental components and pharmaceutical compositions thereof. The compositions have numerous medical applications. Methods for making and using the micronized compositions are also described herein.
Opening claim text (preview).
What is claimed: 1. A sterile pharmaceutical composition comprising a pharmaceutically acceptable fluid carrier and micronized placental tissue particles, said placental tissue particles consisting essentially of an amnion layer and a chorion layer, wherein the chorion layer is layered directly over the amnion layer, wherein the amnion layer has an exposed basement membrane and an exposed fibroblast layer, wherein the intermediate layer of said amnion layer has been substantially removed, wherein the epithelial layer of said amnion layer has been substantially removed, and wherein the micronized placental tissue particles are less than 500 μm. 2. The composition of claim 1 , wherein the pharmaceutically acceptable carrier comprises water, aqueous hyaluronic acid, saline, Ringer's solution, dextrose solution, Hank's solution, a buffer, or an nonaqueous vehicle. 3. The composition of claim 2 , wherein the buffer comprises a phosphate buffer, bicarbonate buffer, or Tris buffer. 4. The composition of claim 1 , wherein the composition is injectable. 5. The composition of claim 1 , wherein the composition is a liquid, gel or paste. 6. The composition of claim 1 , wherein the micronized placental tissue particles are dehydrated. 7. The composition of claim 1 , wherein the micronized placental tissue particles are from 25 μm to 150μm.
Flowable or injectable implant compositions · CPC title
Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells · CPC title
characterised by the function or physical properties of the final product, where no specific conditions are defined to achieve this (A61L27/3687, A61L27/3691 take precedence) · CPC title
Preparations for care of the skin · CPC title
subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.